EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation
TSX:EXE • CA30224T8639
Current stock price
28.71 CAD
+0.37 (+1.31%)
Last:
This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EXE.CA Profitability Analysis
1.1 Basic Checks
- EXE had positive earnings in the past year.
- EXE had a positive operating cash flow in the past year.
- Each year in the past 5 years EXE has been profitable.
- Each year in the past 5 years EXE had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 9.06%, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
- With an excellent Return On Equity value of 25.89%, EXE belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 14.09%, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for EXE is significantly above the industry average of 6.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.06% | ||
| ROE | 25.89% | ||
| ROIC | 14.09% |
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
1.3 Margins
- Looking at the Profit Margin, with a value of 5.82%, EXE belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
- In the last couple of years the Profit Margin of EXE has grown nicely.
- Looking at the Operating Margin, with a value of 8.35%, EXE is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
- In the last couple of years the Operating Margin of EXE has remained more or less at the same level.
- EXE's Gross Margin of 14.26% is on the low side compared to the rest of the industry. EXE is outperformed by 84.62% of its industry peers.
- EXE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.35% | ||
| PM (TTM) | 5.82% | ||
| GM | 14.26% |
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
2. EXE.CA Health Analysis
2.1 Basic Checks
- EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- EXE has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, EXE has more shares outstanding
- Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.05 indicates that EXE is not in any danger for bankruptcy at the moment.
- The Altman-Z score of EXE (4.05) is better than 84.62% of its industry peers.
- The Debt to FCF ratio of EXE is 3.18, which is a good value as it means it would take EXE, 3.18 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 3.18, EXE belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
- EXE has a Debt/Equity ratio of 0.83. This is a neutral value indicating EXE is somewhat dependend on debt financing.
- EXE's Debt to Equity ratio of 0.83 is in line compared to the rest of the industry. EXE outperforms 53.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 3.18 | ||
| Altman-Z | 4.05 |
ROIC/WACC1.8
WACC7.83%
2.3 Liquidity
- A Current Ratio of 1.37 indicates that EXE should not have too much problems paying its short term obligations.
- EXE has a Current ratio of 1.37. This is amongst the best in the industry. EXE outperforms 92.31% of its industry peers.
- A Quick Ratio of 1.37 indicates that EXE should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.37, EXE belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. EXE.CA Growth Analysis
3.1 Past
- EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.99%, which is quite impressive.
- Measured over the past years, EXE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.56% on average per year.
- The Revenue has grown by 13.25% in the past year. This is quite good.
- Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 7.47% on average per year.
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%
3.2 Future
- Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.95% on average per year.
- EXE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.52% yearly.
EPS Next Y16.31%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EPS Next 5YN/A
Revenue Next Year32.28%
Revenue Next 2Y19.54%
Revenue Next 3Y13.52%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. EXE.CA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 25.86 indicates a quite expensive valuation of EXE.
- Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 76.92% of the companies listed in the same industry.
- EXE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.47.
- A Price/Forward Earnings ratio of 23.44 indicates a rather expensive valuation of EXE.
- 76.92% of the companies in the same industry are more expensive than EXE, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 22.62. EXE is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.86 | ||
| Fwd PE | 23.44 |
4.2 Price Multiples
- 69.23% of the companies in the same industry are more expensive than EXE, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.15 | ||
| EV/EBITDA | 15.14 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of EXE may justify a higher PE ratio.
- EXE's earnings are expected to grow with 15.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)1.66
EPS Next 2Y16.61%
EPS Next 3Y15.95%
5. EXE.CA Dividend Analysis
5.1 Amount
- EXE has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.37, EXE pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.81, EXE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
5.2 History
- The dividend of EXE has a limited annual growth rate of 0.28%.
- EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.28%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 43.14% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
- EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.14%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EXE.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:EXE (4/23/2026, 7:00:00 PM)
28.71
+0.37 (+1.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26 2026-02-26
Earnings (Next)05-07 2026-05-07
Inst Owners24.54%
Inst Owner ChangeN/A
Ins Owners1.19%
Ins Owner ChangeN/A
Market Cap2.71B
Revenue(TTM)1.66B
Net Income(TTM)96.66M
Analysts78
Price Target31 (7.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
Yearly Dividend0.47
Dividend Growth(5Y)0.28%
DP43.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-30 2026-04-30 (0.0441)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)26.9%
PT rev (3m)25.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.3%
EPS NY rev (3m)4.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.86 | ||
| Fwd PE | 23.44 | ||
| P/S | 1.63 | ||
| P/FCF | 26.15 | ||
| P/OCF | 16.58 | ||
| P/B | 7.26 | ||
| P/tB | 15.23 | ||
| EV/EBITDA | 15.14 |
EPS(TTM)1.11
EY3.87%
EPS(NY)1.22
Fwd EY4.27%
FCF(TTM)1.1
FCFY3.82%
OCF(TTM)1.73
OCFY6.03%
SpS17.58
BVpS3.95
TBVpS1.89
PEG (NY)1.59
PEG (5Y)1.66
Graham Number9.9357 (-65.39%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.06% | ||
| ROE | 25.89% | ||
| ROCE | 18.83% | ||
| ROIC | 14.09% | ||
| ROICexc | 26.71% | ||
| ROICexgc | 53.72% | ||
| OM | 8.35% | ||
| PM (TTM) | 5.82% | ||
| GM | 14.26% | ||
| FCFM | 6.24% |
ROA(3y)8.19%
ROA(5y)6.95%
ROE(3y)41.67%
ROE(5y)41.08%
ROIC(3y)14.71%
ROIC(5y)10.79%
ROICexc(3y)22.22%
ROICexc(5y)15.92%
ROICexgc(3y)39.32%
ROICexgc(5y)26.96%
ROCE(3y)19.66%
ROCE(5y)14.43%
ROICexgc growth 3Y88.69%
ROICexgc growth 5Y25.88%
ROICexc growth 3Y67.25%
ROICexc growth 5Y13.75%
OM growth 3Y57.94%
OM growth 5Y0.49%
PM growth 3Y0.74%
PM growth 5Y4.46%
GM growth 3Y17.09%
GM growth 5Y-1.93%
F-Score6
Asset Turnover1.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 3.18 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 162.15% | ||
| Cap/Sales | 3.61% | ||
| Interest Coverage | 12.73 | ||
| Cash Conversion | 93.15% | ||
| Profit Quality | 107.28% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 4.05 |
F-Score6
WACC7.83%
ROIC/WACC1.8
Cap/Depr(3y)229.86%
Cap/Depr(5y)237.24%
Cap/Sales(3y)5.46%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.99%
EPS 3Y12.58%
EPS 5Y15.56%
EPS Q2Q%34.86%
EPS Next Y16.31%
EPS Next 2Y16.61%
EPS Next 3Y15.95%
EPS Next 5YN/A
Revenue 1Y (TTM)13.25%
Revenue growth 3Y10.77%
Revenue growth 5Y7.47%
Sales Q2Q%18%
Revenue Next Year32.28%
Revenue Next 2Y19.54%
Revenue Next 3Y13.52%
Revenue Next 5YN/A
EBIT growth 1Y24.69%
EBIT growth 3Y74.95%
EBIT growth 5Y7.99%
EBIT Next Year53.59%
EBIT Next 3Y21.49%
EBIT Next 5YN/A
FCF growth 1Y1.97%
FCF growth 3YN/A
FCF growth 5Y3.29%
OCF growth 1Y13.89%
OCF growth 3Y18.28%
OCF growth 5Y6.16%
EXTENDICARE INC / EXE.CA Fundamental Analysis FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
What is the valuation status for EXE stock?
ChartMill assigns a valuation rating of 4 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
How profitable is EXTENDICARE INC (EXE.CA) stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 7 / 10.
What is the valuation of EXTENDICARE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 25.86 and the Price/Book (PB) ratio is 7.26.
How financially healthy is EXTENDICARE INC?
The financial health rating of EXTENDICARE INC (EXE.CA) is 7 / 10.